Press Releases 3 Investor Relations Press Releases Events Presentations Press Releases Year None20202019201820172016 Mar 25, 2020 DermTech Announces Response to COVID-19 Mar 16, 2020 New Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches Mar 10, 2020 DermTech, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update Mar 05, 2020 Large Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma Detection Mar 03, 2020 DermTech to Participate at the 2020 BTIG Healthcare Conference Mar 02, 2020 DermTech Announces $65 Million Private Placement Feb 11, 2020 DermTech to Present at Upcoming Investor Conferences Jan 16, 2020 DermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion Assay Jan 08, 2020 CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA) Jan 02, 2020 DermTech’s Pigmented Lesion Assay (PLA) Receives Medicare Coverage Investor Tools Print Email Page Email Alerts RSS Feeds Contact IR
Press Releases Year None20202019201820172016 Mar 25, 2020 DermTech Announces Response to COVID-19 Mar 16, 2020 New Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches Mar 10, 2020 DermTech, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update Mar 05, 2020 Large Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma Detection Mar 03, 2020 DermTech to Participate at the 2020 BTIG Healthcare Conference Mar 02, 2020 DermTech Announces $65 Million Private Placement Feb 11, 2020 DermTech to Present at Upcoming Investor Conferences Jan 16, 2020 DermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion Assay Jan 08, 2020 CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA) Jan 02, 2020 DermTech’s Pigmented Lesion Assay (PLA) Receives Medicare Coverage
Mar 16, 2020 New Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches
Mar 10, 2020 DermTech, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Mar 05, 2020 Large Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma Detection
Jan 16, 2020 DermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion Assay
Jan 08, 2020 CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA)
